Sleep Apnea Diagnostic Systems Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Sleep Apnea Diagnostic Systems Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Summary

Sleep Apnea Diagnostic Systems Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Digital Health Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on the Sleep Apnea Diagnostic Systems market for the year 2020 and beyond. The large geriatric population base, suffering from respiratory diseases such as COPD, is the primary driver of the market. The United Nations estimates that the population of individuals of ages over 60 will reach two billion in 2050 with a growth rate of about 3% annually, considerably faster than the population as a whole (UNDESA, 2017). Population aging affects health and healthcare, and medical devices are a crucial component of healthcare delivery. Obstructive sleep apnea (OSA) is one of the most common sleep disorders. Since aging is a risk factor for OSA development, the prevalence will increase with the current increase in life span.

The prevalence of obstructive sleep apnea (OSA), associated with accompanying daytime sleepiness, is approximately 3% to 7% for adult in the general population (Punjabi, 2008), whereas about 13% to 32% of people over 65 years old having sleep apnea (Glasser, 2011). Generally, there is a lack of awareness of the diseases among both the medical community and the public. As a result, the majority of those suffered remain undiagnosed. Disease prevalence is higher in different population subsets, including overweight or obese people and older individuals. It can be expected that with the increasing aging population and prevalence of obesity, the prevalence of OSA will be increasing in future. Moreover, as prevalence estimates of obstructive sleep apnea from North America, Europe, and APAC are not substantially different, it suggests that OSA is common not only in developed but also in developing countries.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Sleep Apnea Diagnostic Systems and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Sleep Apnea Diagnostic Systems market revenue by segment and market outlooks from 2015-2030.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Sleep Apnea Diagnostic Systems.
• Competitive dynamics insights and trends provided for the Sleep Apnea Diagnostic Systems market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered:Koninklijke Philips N.V., ResMed Inc., Natus Medical Inc, Somnomedics GmbH, Compumedics Ltd, Nihon Kohden Corp, Becton Dickinson and Co, Heinen + Lowenstein GmbH & Co. KG, Cadwell Industries Inc, Cleveland Medical Devices Inc, Drive Medical Ltd, Advanced Brain Monitoring Inc, BMC Medical Co., Ltd., Braebon Medical Corp, MEDATEC Sprl, Nox Medical, OSG BVBA and Others

Countries covered:United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• MO executives who must have deep understanding of the Sleep Apnea Diagnostic Systems marketplace to make strategic planning and investment decisions.
• ourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• rivate equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The Model will enable you to -

• nderstand the impact of COVID-19 on Sleep Apnea Diagnostic Systems market.
• evelop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• evelop business strategies by understanding the trends shaping and driving Sleep Apnea Diagnostic Systems market.
• rive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Sleep Apnea Diagnostic Systems market in the future.
• ormulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• dentify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• rack device sales in the global and country-specific Sleep Apnea Diagnostic Systems market from 2015-2030.
• rganize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Please note: this is delivered as an excel file.